Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open-label Clinical Trial to Assess the Safety of Simultaneous Vaccination With mRNA COVID-19 Vaccine and Other Vaccines in Young Children Aged 6 Months to <5 Years.

NCT06038617 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06038617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06038617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open-label Clinical Trial to Assess the Safety of Simultaneous Vaccination With mRNA COVID-19 Vaccine and Other Vaccines in Young Children Aged 6 Months to <5 Years.
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
October 30, 2023
Completion date
July 25, 2025
Enrollment
347 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

fever, fever after vaccination, seizures fever